Polyneuron Pharmaceuticals AG Company
Polyneuron is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases where a pathological role of autoantibodies is well established. Polyneuron’s platform focus is on devastating autoimmune diseases with an unmet medical need.
Founded Date:
2014
Headquarters:
Basel
Industry:
PharmTech